Elixir taps Martha as chief medical officer

Elixir Pharmaceuticals Inc. announced today that Paul M. Martha M.D., an endocrinologist, has been named to the newly created position of chief medical officer.

The Cambridge company is focused on the discovery, development, and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity.
(By Chris Reidy, Globe staff)